chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started with extreme fatigue, then I got facial numbness/?pins and needles?/facial muscle fatigue. I was concerned I was having a stroke. I was driving at the time and almost pulled over to call 911 but I checked my face in the mirror and there wasn?t any facial dropping.  The symptoms improved but didn?t resolve through the evening.
patient presents for a visit today stating he had a reaction yesterday at his work an hour after receiving the flu vaccine. He states he received the flu vaccine (first time getting flu shot), and then an hour later he experienced increased neck pain, and swelling in his bilateral hands and small "water bumps" on his hands, dizziness and lightheadedness. His manager gave him a Benadryl. He stated they offered to send him to the ER but he refused and went home to sleep instead. Since then he has taken another dose of Benadryl and states he feels much better, however still is experiencing small amount of swelling in his hands, no localized reaction to his right arm or neck pain. He denies any shortness of breath, dizziness or further symptoms.
rash and welt at site (immediate reaction and still there) fever that lasted 2 days (began April 10, 2007) back aches (began April 10, 2007-continue) stomach pains (began April 10, 2007 and continue)
This spontaneous report has been received from a pharmacist according to an unspecified website concerning an unknown number patients of unknown age and gender. On an unknown date the patients were diagnosed with measles even though they had received an unspecified number of doses of M-M-R II (dose, route, lot# and received dates unknown). The outcome of the events was not provided. No production quality complaint was reported. Additional information has been requested.
Patient is a 60 years old man who was here for his 1st Moderna Bivalent Booster vaccine. However, he inadvertently received 0.2 mL of Moderna Bivalent booster for 6 month - 5 years old (Lot# 216K22A). Patient left the office in stable condition, no adverse effect. Around 3 pm CDC was contacted and per CDC recommendation, patient returned to the clinic on the same day and received the Moderna Bivalent Booster (18 years old- up) 0.5 mL (Lot# 049D22A). Patient was notified of the adverse event and the CDC recommendation before receiving the correct vaccine. He left the office in stable condition.
LIGHTHEADNESS POST VACCINATION; This spontaneous report was received from a pharmacist via company representative referred to a female patient of an unknown age. The patient's medical history and concomitant medications were not reported. On an unknown date, the pharmacist reported that her son's girlfriend experienced lightheadedness(Dizziness) after receiving a hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (dosing details, route, frequency and lot were unknown) for human papilloma virus immunization. It was reported that the patient had this happened with other unspecified vaccinations or medication administered by injection. The dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) immunization series was unknown. Outcome of dizziness was unknown. Causality assessment was not provided. No PQC found.
no adverse effect; the patient was inadverently administered one dose of expired MMRII along with one dose of expired diluent; This spontaneous report was received from a registered pharmacist referred to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On 16-AUG-2019, the patient was vaccinated with one dose of expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant Human albumin) (M-M-R II) with lot # N027780 expiry date 08-AUG-2019 for prophylaxis along with 1 dose of expired sterile diluent with lot # M029027 with expiry date 14-MAR-2019 (route of administration was not reported) (expired product administered). The pharmacist verified that, the products were stored properly with no temperature excursions through the date of administration. No adverse effects were reported. Product quality complaint was not involved.
Urticaria break outs happening daily.  Triggered by any pressure or friction against the skin.  Still ongoing as of 13Dec2021.
"At the time I received it I instantly had a pain go from my arm up my shoulder into my neck and back of my head."
Severe vertigo,  nausea experiences about 5 min after vaccine admin.  HR regular, skin diaphoretic,  Over course of 15 minutes of observation symptoms subsided,  No dysphagia, redness or swelling at site,  After observation for additional 15 minutes was able to ambulate and feelings of dizziness subsided.  He is not driving and advised to rest for the next 24 hours, and to go immediately to ED or Express Care if any other symptoms develop.
Loss of appetite; generally weak; tired; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), ASTHENIA (generally weak) and FATIGUE (tired) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023N20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FINASTERIDE for an unknown indication.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced DECREASED APPETITE (Loss of appetite), ASTHENIA (generally weak) and FATIGUE (tired). At the time of the report, DECREASED APPETITE (Loss of appetite), ASTHENIA (generally weak) and FATIGUE (tired) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter.  No treatment information was provided.
I have not vomited in 4 years. I just felt pain at the injection site on my arm. It is hard to lift my arm up. I am very nauseous  and vomited today for the first time in 4 years. The symptoms started last night.
There was an opened unlabeled vial of Moderna in the fridge. There had not been any mentions of an open Moderna vial (as when we open each vial we let everyone know . I grabbed the open vial along with an unopened vial of Moderna and proceeded to the clinic. There were 7 doses of this vaccine given to patients. As of 9/27 we were off on our counts and now realize that the vial that was used on 9/24 to those 7 patients was an expired vial. The vial had originally been opened on 9/23 by an RN. These 7 patients have been located and will be contacted once recommendations from CDC are reviewed.
The pt received vaccine on 6/27/00. Pt calls on 7/5/00 to report that on 6/30/00 he began feeling "really draggy", tired, various muscle aching, and headache. He denied nausea, vomiting, fever or chills. He also denied cough or rash. The pt states he started feeling better as of today.
A report has been received from a pharmacist concerning an adult, female subject who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (Intranasal) started on 02-Dec-2014. Pharmacist administered FLUMIST on 02-Dec-2014 which had expired on 24-Nov-2014. The outcome of the event of expired FLUMIST is unknown. The report was considered to be non-serious.
VACCINE ADMINISTERED WAS 5 DAYS PAST THE BEYOND USE DATE FOR THE VACCINE.  IT WAS REFRIGERATED, BUT WAS IN REFRIGERATOR FOR A PERIOD OF 35 DAYS BEFORE ADMINISTERED TO THE PATIENT.
Information has been received from a RN concerning a female child who was vaccinated with measles virus vaccine live  (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Concomitant therapy that day included diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid and poliovirus vaccine. Subsequently, two days later, the pt experienced a seizure and was hospitalized. The pt was
Patient developed redness and swelling not only at the injection site but whole upper arm where the vaccine was administered.
Nausea, weakness, loss of appetite. Treatment (1) prochlorperazine 10mg 1 tab Q6 hours PRN, PEPCID 20mg 1 tab BID.
Case number PHEH2014US005535 is an initial spontaneous report received from a consumer on 18 MAR 2014: This report refers to a female patient of unknown age. Her medical history and concomitant medications were not reported. She was vaccinated with FLUVIRIN (batch number: unknown) and with BOOSTRIX (other manufacturer, batch number: unknown) on an undetermined date. On 02 SEP 2013, after vaccinations, she experienced severe pain all down her right arm. She had to avoid using that arm and pain kept her up at night. She went to her doctor about the pain. Pain completely resolved on 01 DEC 2013. Outcome for the other event (pain kept her up) was not reported. No further information about seriousness and causality was reported.
The patient got really red immediately following vaccination, she started to become woozy and have a headache. We gave her water and a dose of benadryl. We called the ambulance because symptoms kept worsening instead of resolving.
12 yo boy in clinic for 3rd dose Pfizer vaccine due to the use of immunosuppressive therapy. Multiple family members in vaccination room all received different vaccines/doses. The Moderna booster 0.25mL vaccine meant for the father of the child was used to vaccinate the patient rather than the Pfizer 0.3mL vaccine.
First dose more than 25 days before second dose; Half dose received as second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose more than 25 days before second dose) and ACCIDENTAL UNDERDOSE (Half dose received as second dose) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 27-Oct-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose more than 25 days before second dose) and ACCIDENTAL UNDERDOSE (Half dose received as second dose). On 27-Oct-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose more than 25 days before second dose) and ACCIDENTAL UNDERDOSE (Half dose received as second dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported. No Treatment information was reported.  It was reported that, patient who received her first Moderna dose on 20Aug2021. When she returned to the same pharmacy for the second dose on 27-Oct-2021, they inadvertently gave her a booster dose, which was a half dose. The pharmacist looked up the CDC guidance, and their wording was tripping her up. She was hoping for clarification. CDC stated the patient can get another half dose on the same clinic date. The pharmacist states it was been three weeks since the patient received the half dose.
pt recv vax 30JUN97 & 12FEB98 pt presented to MD w/an ear infect & a rash on rt leg;pt had an approx 1cm, circular lesion on rt groin w/possible bruising in the same location;report felt that the lesions were consistent w/herpes zoster;
This spontaneous report was received from a registered pharmacist refers to a patient of unknown age and gender. On 11-APR-2013 the patient was vaccinated with expired ZOSTAVAX (lot # 672606/1655AA, expiration date 21-JAN-2013 and route not reported). Additional information has been requested.
Patient felt dizziness and giddiness. Onsite EMS was called vitals BP 110/74   HR 83 Patient refused evaluation or care, released against medical advise.
A patient received PROQUAD and VARlVAX; This spontaneous report has been received from a physician, and refers to a patient of unknown age and gender. Information regarding the patient's concurrent conditions, medical history and concomitant medications was not provided.    On 07-SEP-2021, at the same time, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (rHA) lot # T029099 and expiration date 23-FEB-2022; and with varicella virus vaccine live (oka/merck)(VARIVAX) lot# T014309 and expiration date 24-APR-2022 (Overdose) (dose, route and anatomical location were not provided for any vaccine) both  for prophylaxis.
Cough, runny nose, congestion, rash on neck, tiredness. No fever.
Day two swelling and soreness and redness and warm to touch.  Normal on fourth day  In the 8th  day - starting itching and when I woke the next morning swelling was back in the Injection site, area was warm to touch, hard when felt and very itching.  About 2 inches by two inches.... same swelling as day  2.  ?CoVid arm?.  I have photos. Of day two and day 9.   I used cortisol e cream and that helped a little. No soreness
8-1 large local reaction in left thigh with erythema and edema increased 7-8 cm oral, central induration, no fever, erythema decreased to 3-4 cm on 8-2, decreased edema, decreased pain
Toothache of unknown origin (dentist cannot find anything and it is not localized), chest pain (not an obvious pattern though somewhat related to exertion), mild chest rash, significant flare of back pain at night
Varivax to (L) upper arm SC. Blister, pain swelling appeared 9-14-07. Started abx therapy with Keflex 250/5.
Fever for two days, body aches, massive headaches. It was almost like having Covid all over again!
Initial information has been received from a physician concerning a 4 year old female with no medical history and no allergies, who on 15-AUG-2008 was vaccinated with VARIVAX (lot # 661011/0608X).  On 15-AUG-2008, the patient fainted for a couple of minutes in the office.  When she was taken back into an exam room, the patient had a jerking episode, her eyes rolled back and the patient stiffened, which lasted under 5 minutes.  The patient was monitored and given a Popsicle.  The patient recovered on 15-AUG-2008.  She was discharged from the office to home with her mother.  Follow-up information was received from a nurse via phone call.  On 16-AUG-2008, the patient's mother was contacted by phone and the patient's mother reported that the patient was "fine".  Upon internal review, the petit mal seizure was considered to be an Other Important Medical Event.  Additional information has been requested.
Reaction to MMR injection in right upper arm. Had 10mm wheal approx. 4mm distal from injection site with 50mm erythema surrounding wheal. Treated with Benadryl. DTAP given IM in left deltoid, pt and mother instructed to go to ER for evaluation. Pt stable, alert and without difficulty breathing. On 8/23/00, per phone call to check up on pt, mom states they over 30 minutes and she was doing fine. Redness was nearly gone, so they left without being seen. I instructed her to phone doctor immediately if any abnormal symptoms and later after stabilized to call us. On 8/25, I phoned to check up on pt and mom states she's fine and had no further problems. I reminded her of the possibility of further side effects in 7-14 days and to call if any unexpected symptoms.
did not get the 2nd dose within 6 months; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The case was reported by the consumer for herself/himself. The age at vaccination was not applicable to this report. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
vaccine doesn´t prevent. She had the shots and had them twice/ suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspect vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The case was reported by patient husband. The age at vaccination was not reported. The patient received shingle shot and had them twice. The reporter stated that the shingle shots will not 100 percent prevent shingles. the shots only prevent the severity of shingles. The follow up would not be possible as no contact details were available. This case was considered to be a suspected vaccination failure case, as the details regarding time to onset and laboratory confirmation for shingles were unknown.
My arm has moderate injection site pain; the shot popped apart at the threaded portion of the syringe, vaccine went everywhere; Vaccine went everywhere; it was unclear if any made it into my arm; keeps me awake at night; painful to raise higher than elbow height; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A 38-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 16Apr2021 14:15 (Batch/Lot number: unknown) at the age of 38 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: bnt162b2 (Dose 1, single (Lot Number: Not provided) in the left arm at 02:15 PM), administration date: 19Mar2021, when the patient was 38 years old, for COVID-19 immunisation. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 16Apr2021 14:15, outcome "unknown", described as "My arm has moderate injection site pain"; MIDDLE INSOMNIA (non-serious) with onset Apr2021, outcome "unknown", described as "keeps me awake at night"; PAIN IN EXTREMITY (non-serious) with onset Apr2021, outcome "unknown", described as "painful to raise higher than elbow height"; PRODUCT LEAKAGE (non-serious) with onset 16Apr2021 14:15, outcome "unknown", described as "the shot popped apart at the threaded portion of the syringe, vaccine went everywhere"; ACCIDENTAL EXPOSURE TO PRODUCT (non-serious) with onset 16Apr2021 14:15, outcome "unknown", described as "Vaccine went everywhere"; INCORRECT DOSE ADMINISTERED (non-serious) with onset 16Apr2021 14:15, outcome "unknown", described as "it was unclear if any made it into my arm". Therapeutic measures were not taken as a result of vaccination site pain, middle insomnia, pain in extremity.  Additional Information: During injection, the needle was inserted into patient's left arm. Once inserted, the person administering the shot pushed the syringe, and the shot popped apart at the threaded portion of the syringe. Vaccine went everywhere and it was unclear if any made it into her arm. The person administering the shot was surprised, but said that it 'has happened before'. The needle was still in her left arm, was pulled out, and another vaccine was quickly prepared and administered without issue. The patient's arm had moderate injection site pain (kept her awake at night and painful to raise higher than elbow height). The patient did not receive other vaccine in four weeks and other medications in two weeks. The patient was not diagnosed with COVID prior vaccination, was not tested for COVID post vaccination, and had no known allergies.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
The first couple of days after the vaccine I had mild to moderate headaches and fatigue, no chills.  Lasted about a day.  After a week from the vaccine, at night I noticed my arm was hurting and it was red and was hot to the touch and swollen and hard about 3"X3" square right under the injection site. It was also painful. Very sore and hot and hard and red.  I submitted an email to my PCP via the patient portal. She recommended me to take some Benadryl and Advil or Tylenol. I took the Benadryl and Tylenol and put ice on it. The symptoms finally started to get better about 2 days later and 4-5 days later it was much better and totally gone in about 5 days.
June 14, 2022: 5pm, hives on right inner elbow, treatment:  took Benadryl  June 16, 2022:  8:30pm, hives on right inner elbow and both inner upper thighs, treatment:  took Benadryl
The nurse sated that she reconstituted the 5-11 year old  Pfizer Covid-19 vaccine with 1.8 ml of 0.9% of normal saline instead of 1.3 ml.
Per pt : had midsternal chest pain for a few min the day of the first infection and then resolved . SHe mentioned that the the vaccine center during the second shot  got mid sernal chest pain x 2 for a few min each time after the second dose _ within 24 hr of the vaccine and self resolved.  + arthralgia's and muscle aches throughout the time   She presented on 5/15/2021 with complains of chest pain in the midsternal area and to bilateral sides, no radiation and felt like pressure.  EKG pertinent for v2,v3 TWI new from before. Troponin  from 0.02--3.5 L heart Cath 5/17:   No CAD , Normal LVEF  Ct chest PE protocol : neg  MRI heart :5/18:  acute focal myocarditis left mid inferolateral segment with focal myocardial edema and fibrosis  LYME AB SCREEN (Outside Lab) Latest Units: index  <0.90 Negative SARS CoV 2 AB IGG (Outside Lab)    Negative SARS COV 2 AB (IGG) SPIKE, SEMI QN Latest Ref Range: <1.00 index       >20.00 (H) Adenovirus PCR    Not Detected   Enterovirus PCR    Not Detected     Sars-Cov-2 (Covid 19) by PCR Negative       CYTOMEGALOVIRUS ANTIBODY (IGG) (Outside Lab) Latest Units: U/mL     >10.00 (H)   CYTOMEGALOVIRUS ANTIBODY (IGM) (Outside Lab) Latest Units: AU/mL     <30.00   EchoV T6 Ab      <1:10 EchoV T7 Ab       <1:10 EchoV T9 Ab      <1:10 EchoV T11 Ab     <1:10 EchoV T30 Ab     <1:10 EBV VIRAL CAPSID AG (VCA) AB (IGM) (Outside Lab)      <36.00 EBV VIRAL CAPSID AG (VCA) AB (IGG) (Outside Lab)       242.00 (H) EBV NUCLEAR AG (EBNA) AB (IGG) (Outside Lab)        252.00 (H) INTERPRETATION (Outside Lab) Unknown       PAST INFECTION HERPESVIRUS 6 AB (IGG) (Outside Lab)  1:20 (H) HERPESVIRUS 6 AB (IGM) (Outside Lab) <1:20 INFLUENZA TYPE B ANTIBODY SERUM (Outside Lab) Latest Ref Range: <1:8 titer       1:8 (H) PARVOVIRUS B19 ANTIBODY (IGG) (Outside Lab) Unknown       0.2 INFLUENZA TYPE A ANTIBODY SERUM (Outside Lab) Latest Ref Range: <1:8 titer       1:32 (H) PARVOVIRUS B19 ANTIBODY (IGM) (Outside Lab) Unknown       0.1 HIV 1 And 2 Latest Ref Range: Non-Reactive        Non-Reactive